Xylem (NYSE: XYL) reported Q4 EPS of $1.18, $0.05 better than the analyst estimate of $1.13. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.18 billion.

GUIDANCE:

Xylem sees FY2025 revenue of $8.6-8.7 billion, versus the consensus of $8.837 billion.

Full-year 2025 adjusted EBITDA margin is expected to be approximately 21.3 to 21.8 percent, an increase of 70 to 120 basis points from Xylem’s 2024 adjusted results. Full-year free cash flow margin is expected to be approximately 9 to 10 percent.

For earnings history and earnings-related data on Xylem (XYL) click here.